DENTSPLY SIRONA (NASDAQ:XRAY) Rating Reiterated by Piper Sandler

DENTSPLY SIRONA (NASDAQ:XRAY)‘s stock had its “neutral” rating restated by stock analysts at Piper Sandler in a research note issued to investors on Friday, Benzinga reports. They presently have a $32.00 price objective on the medical instruments supplier’s stock, down from their prior price objective of $35.00. Piper Sandler’s price objective points to a potential upside of 13.11% from the stock’s current price.

Several other research firms have also recently commented on XRAY. Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating on the stock in a research report on Friday. SVB Leerink started coverage on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. They set an “outperform” rating and a $42.00 target price on the stock. StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday, January 19th. Needham & Company LLC decreased their price target on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating for the company in a research note on Friday. Finally, Leerink Partnrs restated an “outperform” rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. Five research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $36.90.

DENTSPLY SIRONA Trading Down 0.3 %

Shares of NASDAQ XRAY opened at $28.29 on Friday. DENTSPLY SIRONA has a fifty-two week low of $26.27 and a fifty-two week high of $41.65. The company has a quick ratio of 0.95, a current ratio of 1.43 and a debt-to-equity ratio of 0.54. The firm’s 50-day simple moving average is $32.13 and its 200 day simple moving average is $32.71.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, meeting the consensus estimate of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The business had revenue of $953.00 million for the quarter, compared to analysts’ expectations of $969.45 million. During the same quarter last year, the firm earned $0.39 EPS. The firm’s revenue for the quarter was down 2.6% compared to the same quarter last year. As a group, research analysts forecast that DENTSPLY SIRONA will post 2.04 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of XRAY. Vanguard Group Inc. grew its position in shares of DENTSPLY SIRONA by 1.5% during the 3rd quarter. Vanguard Group Inc. now owns 25,250,443 shares of the medical instruments supplier’s stock valued at $862,555,000 after purchasing an additional 369,213 shares in the last quarter. Nuance Investments LLC grew its position in shares of DENTSPLY SIRONA by 30.4% during the 4th quarter. Nuance Investments LLC now owns 11,603,889 shares of the medical instruments supplier’s stock valued at $412,982,000 after purchasing an additional 2,702,457 shares in the last quarter. First Eagle Investment Management LLC grew its position in shares of DENTSPLY SIRONA by 1.2% during the 4th quarter. First Eagle Investment Management LLC now owns 9,786,845 shares of the medical instruments supplier’s stock valued at $348,314,000 after purchasing an additional 120,508 shares in the last quarter. Wellington Management Group LLP grew its position in shares of DENTSPLY SIRONA by 21.1% during the 4th quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock valued at $289,640,000 after purchasing an additional 1,419,503 shares in the last quarter. Finally, Cooke & Bieler LP grew its position in shares of DENTSPLY SIRONA by 18.3% during the 4th quarter. Cooke & Bieler LP now owns 7,061,910 shares of the medical instruments supplier’s stock valued at $251,333,000 after purchasing an additional 1,092,922 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.